XML 28 R17.htm IDEA: XBRL DOCUMENT v2.4.1.9
4. Segment Information and Concentrations (Tables)
 6 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Segment Information
   Benchtop
Laboratory
Equipment		   Catalyst
Research
Instruments		   Bioprocessing
Systems		   Corporate
and
Other		   Consolidated 
                          
Three months ended December 31, 2014:                         
                          
Revenues  $1,247,000   $419,600   $24,500   $-   $1,691,100 
Foreign Sales   722,400    315,700    -    -    1,038,100 
Loss from Operations   (67,200)   (70,600)   (44,700)   -    (182,500)
Assets   4,032,700    1,387,900    774,100    585,800    6,780,500 
Long-Lived Asset Expenditures   33,200    -    2,300    -    35,500 
Depreciation and Amortization   76,300    9,200    24,500    -    110,000 

 

   Benchtop
Laboratory
Equipment		   Catalyst
Research
Instruments		   Bioprocessing
Systems		   Corporate
and
Other		   Consolidated 
                          
Three months ended December 31, 2013:                         
                          
Revenues  $1,154,000   $463,400   $130,400   $-   $1,747,800 
Foreign Sales   823,400    88,900    -    -    912,300 
Income (Loss) from Operations   119,800    2,100    64,600    (10,000)   176,500 
Assets   2,787,400    1,704,400    981,600    829,800    6,303,200 
Long-Lived Asset Expenditures   10,100    -    6,000    -    16,100 
Depreciation and Amortization   11,600    8,500    24,200    -    44,300 

 

   Benchtop
Laboratory
Equipment		   Catalyst
Research
Instruments		   Bioprocessing
Systems		   Corporate
and
Other		   Consolidated 
                          
Six months ended December 31, 2014:                         
                          
Revenues  $2,333,400   $970,700   $49,100   $-   $3,353,200 
Foreign Sales   1,133,500    759,200    -    -    1,892,700 
Loss from Operations   (185,300)   (140,800)   (85,100)   -    (411,200)
Assets   4,032,700    1,387,900    774,100    585,800    6,780,500 
Long-Lived Asset Expenditures   51,500    900    3,900    -    56,300 
Depreciation and Amortization   152,300    19,000    48,800    -    220,100 

 

   Benchtop
Laboratory
Equipment		   Catalyst
Research
Instruments		   Bioprocessing
Systems		   Corporate
and
Other		   Consolidated 
                          
Six months ended December 31, 2013:                         
                          
Revenues  $2,223,700   $803,100   $157,100   $-   $3,183,900 
Foreign Sales   1,444,200    162,400    2,000    -    1,608,600 
Income (Loss) from Operations   238,100    (101,900)   47,800    (10,500)   173,500 
Assets   2,787,400    1,704,400    981,600    829,800    6,303,200 
Long-Lived Asset Expenditures   20,000    -    6,500    -    26,500 
Depreciation and Amortization   22,600    17,600    48,300    -    88,500